Closing the clinical gap MyBiotics developed a wide range of tailor-made solutions to overcome many of the known limitations related to Bio-therapeutic bacteria-based products. Proven survival during production and improved engraftment of human core bacteria bridge between probiotics and the huge potential of the microbiome as a drug.
Learn more
Innovative technology platform MyBiotics developed several innovative technologies for single and multi-strain fermentation combined with the state of the art in formulation capabilities. All supported by an artificial donor biological bank and AI discovery platforms for better products and clinical outcomes.
Learn more
Therapeutic program MyBiotics developed MBX-SD-201 and MBX-SD-202 for treating acute CDI MyBiotics is the world’s first company to produce an artificial donor biological bank. Additional products for oncology, gastro and woman’s health are under development.
Learn more
About

MyBiotics is developing live biotherapeutic products based on the company’s unique discovery, delivery, and colonization technologies.

learn More

TECHNOLOGY

Potential superior clinical effect and proven bacterial colonization using MyCrobe™ and SuperDonor™ technology.

learn More

Products

MBX-SD-201 and MBX-SD-202 for CDI and MBX-MC-101 for acute dysbiosis bring MyBiotics breakthrough technologies to the product development stage.

learn More

about

MyBiotics

MyBiotics is a clinical-stage microbiome company developing live bacteria based therapeutics.

The human body carries about 100 trillion microorganisms in the intestines, a number ten times greater than the total number of human cells in the body. The metabolic activities performed by these bacteria resemble those of an organ, leading some to liken gut bacteria to a “forgotten” organ.

The microorganisms in the gut carry out important and useful functions in the host, such as fermenting unused energy substrates, training the immune system, preventing growth of harmful and pathogenic bacteria, regulating the development of the gut, producing vitamins for the host, such as biotin, B-12 and vitamin K, and producing hormones that direct the host to store fats. Ingestion of processed foods, excessive use of antibiotics, and the sanitary customs of modern life , erodes the bacterial population, and changes its balance.

our solutions

Products & Technology

MyBiotics Pharma is developing live biotherapeutic products based on the company’s unique technologies for culturing, formulation and production to enable improved viability, efficient delivery and colonization.

We apply unique cultivation technologies, advanced fermentation and formulation, combined with a computational discovery & optimization platform. Our technologies platform covers single-strain, pre-designed consortia, and human-derived complex microbial populations.

mybiotics

Vision

Use our technology to make a real and long lasting impact on human health.

Our vision is to bring scientific excellence to the world of probiotics, by developing clinically proven products, and make a real and long lasting impact on human health. We intend to achieve this goal by using our innovative technologies and combine it with our strong scientific, medical and industrial knowhow and team expertise.
We develop effective and long lasting probiotic and microbiome treatments with a proved clinical advantages.

Mybiotics goal is to efficiently design and produce our probiotic products to address the most common and unsolved health problems by restoring balance to the microbiota and improving health.

News & Updates